Breastfeeding may decrease risk of pediatric acute lymphoblastic leukemia
the ONA take:
According to a new study, researchers from Telethon Kids Institute in Perth, Australia, have found that breastfeeding a child may reduce that child's risk of developing pediatric acute lymphoblastic leukemia (ALL).
For the study, researchers assessed whether breastfeeding, introducing solid foods, or early diet were associated with ALL or childhood brain tumors (CBT). Mothers of both healthy children and children with ALL or CBT completed a questionnaire about their child's dietary consumption up until the child was 2 years of age.
Mothers were asked whether they breasted their child and for what duration, whether they used baby formula, and when they started feeding their child solid foods. Results showed that children who were fed with formula were more likely to develop ALL, which researchers suggest is due to the absence of breastfeeding.
They found no link between breastfeeding and CBT, which may be because brain tumors develop through a different mechanism versus ALL. The researchers note that evidence is only suggestive of an association.
Breastfeeding a child may reduce that child's risk of developing pediatric acute lymphoblastic leukemia (ALL).
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|